Oak Thistle LLC’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.3M Buy
+4,361
New +$2.45M 0.22% 178
2026
Q1
Sell
-1,168
Closed -$790K 549
2025
Q4
$790K Buy
+1,168
New +$795K 0.11% 365
2025
Q3
Sell
-2,843
Closed -$1.52M 546
2025
Q2
$1.52M Buy
+2,843
New +$1.36M 0.22% 164
2025
Q1
Sell
-1,031
Closed -$426K 489
2024
Q4
$426K Buy
+1,031
New +$452K 0.13% 276
2024
Q3
Sell
-869
Closed -$423K 464
2024
Q2
$423K Buy
869
+319
+58% +$160K 0.31% 138
2024
Q1
$297K Buy
+550
New +$301K 0.27% 174
2023
Q4
Sell
-830
Closed -$363K 528
2023
Q3
$363K Buy
830
+265
+47% +$132K 0.11% 357
2023
Q2
$284K Sell
565
-372
-40% -$178K 0.15% 263
2023
Q1
$469K Buy
+937
New +$448K 0.28% 152
2022
Q2
Sell
-724
Closed -$396K 287
2022
Q1
$396K Buy
+724
New +$381K 0.21% 216

Other funds holding IDXX

Oak Thistle LLC's IDXX Position: Q2 2026 in Review

Oak Thistle LLC opened a new position in Idexx Laboratories (IDXX) in Q2 2026: 4,361 shares worth $2.3M. The stake represents 0.22% of the portfolio and ranks #178 among its holdings. This is a return to the name: Oak Thistle LLC previously reported a position in IDXX as recently as Q4 2025.

Oak Thistle LLC first reported a position in IDXX in Q1 2022 and has held it in 10 quarters since. 1,295 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Oak Thistle LLC held 4,361 shares of Idexx Laboratories worth $2.3M as of Q2 2026.
  • Idexx Laboratories was a new Oak Thistle LLC position in Q2 2026.
  • Idexx Laboratories made up 0.22% of Oak Thistle LLC's portfolio in Q2 2026, its #178 holding.
  • Oak Thistle LLC first reported a position in Idexx Laboratories in Q1 2022 and has held it in 10 quarters since.
  • 1,295 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Oak Thistle LLC's 13F filing for Q2 2026, filed 21 Jul 2026.